Insights on Discovery
-
What ASCO 2025 Means For The Future Of Oncology Trials
6/13/2025
Review the ASCO 2025 Annual Meeting, highlighting oncology trials and the need for agile, globally capable CRO partners to navigate today’s evolving trial landscape.
-
Factors Influencing CD34+ Cell Collection Efficiency In Leukapheresis
6/3/2025
Efficiently collecting sufficient peripheral blood stem cells is paramount for successful transplantation, necessitating a deeper understanding of influencing factors and procedural nuances.
-
Broad Biodistribution And Expression Of Allele-Selective LETI-101
5/28/2025
Discover how LETI-101, a novel precision-based CRISPR treatment, can leverage targeted delivery and broad brain distribution to transform Huntington's disease treatment.
-
CRISPR Portfolio, Modalities Accelerate Candidate Identification
5/28/2025
See how this cutting-edge, AI-driven genome editing technology can accelerate the development of precise, clinically viable therapies for genetic diseases.
-
Peripheral Blood Mononuclear Cell (PBMC) Isolation Using Cell Fractionation Filters
5/28/2025
Discover how this Peripheral Blood Mononuclear Cell (PBMC) isolation method can transform CAR-T manufacturing by reducing costs, accelerating timelines, and improving patient accessibility.
-
Signature Of Base Editor RNA Edits And Reduced Exogenous RNA Editing
5/28/2025
Learn how this groundbreaking method for distinguishing base editor-induced RNA edits can enhance the safety and efficacy of genomic medicines.
-
Electroporation, LNPs For Targeted CRISPR/Cas9 Gene Editing In T-Cells
5/28/2025
This study compared non-viral transfection methods in primary human T-cells, demonstrating the feasibility of an LNP-based process encapsulating CRISPR/Cas9 and HDR template DNA in a single payload.
-
CRISPR-Associated RNA-Guided Nucleases For Precise Gene Editing
5/28/2025
Explore how advanced CRISPR technologies and proprietary delivery systems are transforming genomic medicine by enabling precise gene editing for a wide range of therapeutic applications.
-
CRISPR System Enables CNS Biodistribution, mHTT Protein Reduction
5/28/2025
Discover how a diverse collection of RNA-guided nucleases, base editors, and reverse transcriptase editors with unique PAM recognition sequences can enable flexible and precise genome editing.
-
AAV Vector Used To Deliver Gene Editing Tools To The Brain
5/28/2025
Discover how LETI-101's promising preclinical results and advanced manufacturing strategies are advancing gene editing therapy for Huntington's Disease.